ONS-derived A-T iPSC, hONS-derived A-T iPSC, A-T HL iPSC
Australian Institute for Bioengineering and Nanotechnology
Griffith Institute for Drug Discovery Neuro Bank
Name: Human olfactory neurosphere derived cells
Accession Identifier: {{ cell_source.external_cell_line_source.xref_id }}
Disease: {{ cell_source.external_cell_line_source.disease_phenotype.name }}
Source Cell Type: N/A
Source Cell Origin:
UBERON:0005386
Label: olfactory segment of nasal mucosa
Definition:
That portion of the nasal mucosa containing the sensory endings for olfaction; the organ of smell[MESH].
Derivation Year: 2018
Vector Type:
Vector: Other
Kit: [kit] ReproRNA-OKSGM
Detected: {{ details.non_integrated_vector.get_detected_reprogramming_vector_display }}
Ethics Number: 2019000159
Institution Human Research Ethics Council: Queensland Children's Health Services Human Ethics Committee
Approval Date: To be verified
Passage Number: 5
Karyotype: 46,XX
Karyotype Method: G-banding
Summary: Karyotyping occurred from passage 5 at a resolution of 500bphs.
STR analysis Results:
Performed but not available.| Disease | Result |
|---|---|
| Mycoplasma | Negative |
| Marker | Method |
|---|---|
| NANOG | Immunostaining |
| OCT4 | Immunostaining |
| SOX2 | Immunostaining |
| TRA-1-60 | Immunostaining |
| TRA-1-81 | Immunostaining |
No available data for this cell line.
No available data for this cell line.
In vitro directed differentiation
Assessed by: RT-qPCR
Markers: CXCR4; FOXA2; SOX17
In vitro directed differentiation
Assessed by: RT-qPCR
Markers: CD34; HAND1; KDR; PDGFRA
In vitro directed differentiation
Assessed by: RT-qPCR
Markers: NR2F2; OTX2; PAX6; VIM
CO2 concentration: 5%
O2 concentration: Unavailable
Medium Items:
Passage Method: Enzyme-free cell dissociation